(Q42412765)

30 October 2017

Is it safer CARs that we need, or safer rules of the road? (English)

1 reference

30 October 2017

Richard P Junghans

1

1 reference

30 October 2017

1 October 2010

1 reference

30 October 2017

1 reference

30 October 2017

18

1 reference

30 October 2017

10

1 reference

30 October 2017

1742-1743

1 reference

Strategy escalation: an emerging paradigm for safe clinical development of T cell gene therapies

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

The T-body approach: redirecting T cells with antibody specificity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologic malignancies in experimental and clinical studies.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2951568

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

28 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20885432

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20885432

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/MT.2010.162

1 reference

release_i5llxrukxfcr7jm3gp2hjlbzeu

30 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i5llxrukxfcr7jm3gp2hjlbzeu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

2951568

1 reference

PMC publication ID

2951568

30 October 2017

PubMed publication ID

20885432

1 reference

PMC publication ID

2951568